drugset / Trial / NCT06527222
A Study of Ranolazine in ALS
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate safety, effect on cramps, function and quality of life of ranolazine versus placebo for the treatment of ALS.
Timeline
- Start
- 2025-04-29
- Primary completion
- 2028-07
- Completion
- 2028-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ranolazine | Small molecule | 500 mg | Oral |
| Subject | Ranolazine | Small molecule | 1000 mg | Oral |